Personalis, Inc.
PSNL Nasdaq· Services-Medical Laboratories
Last close · Oct 23, 2026
$15.85
KIRA · Stoqly’s AI analyst, in plain words
- Personalis, Inc. had $69.6M of revenue in fiscal 2025, down 17.7% on the year before. Over five years, revenue changed −2.4% a year on average.
- Its operating margin was −126.4%, down 45.8 pts: of every 100 in sales, about −126 is left after running the business.
- Personalis, Inc. lost $81.3M in fiscal 2025.
- Free cash flow was −$79.5M in fiscal 2025, −114.1% of revenue.
Market cap
$1.7B
P/E
—
Revenue
$69.6M
Net income
−$81.3M
Free cash flow
−$79.5M
Operating margin
−126.4%
Personalis, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−17.7%
No. Sales fell 17.7% last year.
Does it make a profit?
−116.7%
No. It lost money last year.
Does profit turn into cash?
−114.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Personalis, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- Personalis, Inc.
- CIK
- 0001527753
Personalis, Inc. · PSNL
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $85.5M | $65.0M | $73.5M | $84.6M | $69.6M |
| Revenue growth | 8.7% | −23.9% | 13.0% | 15.2% | −17.7% |
| Gross margin | 37.0% | 20.5% | 24.8% | 31.7% | 22.7% |
| Operating margin | −76.4% | −177.6% | −149.6% | −80.7% | −126.4% |
| Net income | −$65.2M | −$113M | −$108M | −$81.3M | −$81.3M |
| Net margin | −76.3% | −174.2% | −147.4% | −96.1% | −116.7% |
| Diluted EPS | −$1.49 | −$2.48 | −$2.25 | −$1.37 | −$0.91 |
| Cash | |||||
| Cash from operations | −$70.8M | −$70.2M | −$56.3M | −$45.2M | −$74.9M |
| Capital expenditure | $11.1M | $49.9M | $10.9M | $1.6M | $4.5M |
| Free cash flow | −$81.9M | −$120M | −$67.2M | −$46.8M | −$79.5M |
| FCF margin | −95.8% | −184.7% | −91.4% | −55.3% | −114.1% |
| Share count change | 27.7% | 4.1% | 5.4% | 23.0% | 50.6% |
| Debt and strength | |||||
| Cash and short-term investments | $287M | $168M | $114M | $185M | $240M |
| Shareholders' equity | $310M | $218M | $129M | $203M | $261M |
| Current ratio | 10.2x | 6.0x | 3.1x | 6.5x | 6.8x |
| Interest coverage | −355.2x | −574.8x | −999.4x | −2,844.5x | −429.5x |
| Returns and quality | |||||
| Return on equity | −25.8% | −42.9% | −62.3% | −48.9% | −35.0% |
| Return on tangible equity | −21.0% | −51.9% | −83.7% | −40.0% | −31.1% |
| Piotroski F-score | 3 | 2 | 3 | 4 | 3 |
| Altman Z'' | 5.4 | 0.1 | −5.7 | −1.0 | 0.3 |
Insiders bought, 12 months
$2.7M
1 insider
Insiders sold, 12 months
$8.8M
4 insiders
Of sales under plans
94%
$8.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Personalis, Inc. · PSNL
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $15.85 a share, the company is worth $1.7B.
Source: SEC EDGAR XBRL filings (CIK 0001527753). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.